- certolizumab
-
A particular monoclonal antibody used in the treatment of Crohns disease.
Wikipedia foundation.
Wikipedia foundation.
Certolizumab — pegol Größe 147 kDa Bezeichner Externe IDs … Deutsch Wikipedia
Certolizumab pegol — ? Monoclonal antibody Type Fab fragment Source Humanized (from mouse) Target TNF alpha Clinical data AHFS/Drugs.com … Wikipedia
Certolizumab pegol — Masse/Länge Primärstruktur 147 kDa … Deutsch Wikipedia
certolizumab pegol — cer·to·liz·u·mab peg·ol (ser to lizґu mab) a tumor necrosis factor blocker used for reduction of signs and symptoms of Crohn disease; administered by subcutaneous injection … Medical dictionary
UCB Pharma S.A. — UCB S.A. Unternehmensform Société Anonyme ISIN … Deutsch Wikipedia
UCB S.A. — UCB S.A. Unternehmensform Société Anonyme ISIN … Deutsch Wikipedia
Daclizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD25 Clinical data Trade names Zenapax AHFS/Drugs.com … Wikipedia
Omalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IgE Fc region … Wikipedia
Natalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target alpha 4 integrin Clinical data Trade names Tysabri AHFS/ … Wikipedia
Treatment of Crohn's disease — involves first treating the acute symptoms of the disease, then maintaining remission. Treatment initially involves the use of medications to eliminate infections, generally antibiotics, and reduce inflammation, generally aminosalicylate anti… … Wikipedia